L707-0796 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{7-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl}acetamide

L707-0796 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{7-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl}acetamide
L707-0796 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{7-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L707-0796
N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{7-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L707-0796

Molecular Formula

C26H37N3O4S (C26 H37 N3 O4 S)

Compound Name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{7-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl}acetamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{7-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-2345-tetrahydro-1H-1-benzazepin-1-yl}acetamide

SMILES

CC(CC1)CCN1S(c(cc1)cc(CCC2)c1N(CC(NCCC1=CCCCC1)=O)C2=O)(=O)=O

InChI

InChI=1S/C26H37N3O4S/c1-20-13-16-28(17-14-20)34(32,33)23-10-11-24-22(18-23)8-5-9-26(31)29(24)19-25(30)27-15-12-21-6-3-2-4-7-21/h6,10-11,18,20H,2-5,7-9,12-17,19H2,1H3,(H,27,30)

InChI Key

OKNCXICWFJATOG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27471992

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

487.66

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.858

Distribution Coefficient, logD

3.858

Water Solubility, LogSw

-3.96

Polar Surface Area

72.166

Acid Dissociation Constant (pKa)

15.04

Base Dissociation Constant (pKb)

0.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

61.50

L707-0796 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L707-0796 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L707-0796?
Check Price and Availability of L707-0796, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L707-0796 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L707-0796
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L707-0796
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L707-0796 available by request